Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

per Massuti, Bartomeu, Sanchez, Jose Miguel, Hernando-Trancho, Florentino, Karachaliou, Niki, Rosell, Rafael
Publicat a Transl Lung Cancer Res (2013)

When the Need is Greater Than Feasible

per Fraile Olivero, Carlos Alfredo, Jarabo Sarceda, José Ramón, Cerdán Santacruz, Carlos, Santos Capa, Passio, Arribas Manzanal, Pedro Daniel, Barriuso, Rafael, Hernando Trancho, Florentino
Publicat a Arch Bronconeumol (2020)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

per Mielgo-Rubio, Xabier, Calvo, Virginia, Luna, Javier, Remon, Jordi, Martín, Margarita, Berraondo, Pedro, Jarabo, José Ramón, Higuera, Oliver, Conde, Esther, De Castro, Javier, Provencio, Mariano, Hernando Trancho, Florentino, López-Ríos, Fernando, Couñago, Felipe
Publicat a Cancers (Basel) (2020)

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey

per Martínez-Hernández, Néstor J., Caballero Silva, Usue, Cabañero Sánchez, Alberto, Campo-Cañaveral de la Cruz, José Luis, Obeso Carillo, Andrés, Jarabo Sarceda, José Ramón, Sevilla López, Sebastián, Cilleruelo Ramos, Ángel, Recuero Díaz, José Luis, Call, Sergi, Couñago, Felipe, Hernando Trancho, Florentino
Publicat a Cancers (Basel) (2021)

Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations

per Jarabo Sarceda, José Ramón, Bolufer Nadal, Sergio, Mongil Poce, Roberto, López de Castro, Pedro, Moreno Balsalobre, Ramón, Peñalver Cuesta, Juan Carlos, Embún Flor, Raul, Pac Ferrer, Joaquín, Algar Algar, Francisco Javier, Gámez García, Antonio Pablo, Jiménez, Marcelo F., Sales-Badía, Jesús Gabriel, Pereira, Eva, Massuti, Bartomeu, Provencio, Mariano, Hernando Trancho, Florentino
Publicat a Transl Lung Cancer Res (2021)